2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Lichen Sclerosus et Atrophicus: new trials by email Literature Review of Lichen Sclerosus et Atrophicus trials Research Report on Lichen Sclerosus et Atrophicus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus Delgocitinib, Cream Vehicle - Lichen Sclerosus | Phase 3 | Recruiting | LEO Pharma | 652 | 2026-05-01 | 2026-10-13 |
| Laser vs Clobetasol for Lichen Sclerosus Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser - Lichen Sclerosus | Phase 3 | Completed | Ruhr University of Bochum | 246 | 2021-11-02 | 2025-12-04 |
| Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus Fractionated Carbon Dioxide Laser, Clobetasol Propionate 0.05% ointment - Vulvar Lichen Sclerosus | Phase 3 | Completed | Medstar Health Research Institute | 52 | 2015-10-01 | 2021-10-12 |
Vulvar Lichen Sclerosus (1) · Vulvodynia (1)
Lichenoid Eruptions (3) · Skin Diseases (3) · Skin Diseases, Papulosquamous (3) · Skin and Connective Tissue Diseases (3) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Urogenital Diseases (1) · Vulvar Diseases (1)
Clobetasol (2) · Ointments (1) · delgocitinib (1)
LEO Pharma (1) · Medstar Health Research Institute (1) · Ruhr University of Bochum (1)
United States (2) · Canada (1) · Germany (1) · United Kingdom (1)
Cheryl Iglesia, MD (1) · Clemens B Tempfer, MD (1)
2025 (1)